Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology

NEXT STORY
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program
PREV STORY
Republic First Bancorp, Inc. Reports First Quarter Financial Results Loans Grow 27% and Deposits Increase by 19%
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Madrigal Pharmaceuticals Announces Three Abstracts Accepted by The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting in November 2020, including Positive Data from Ongoing Open Label Arm of Resmetirom 52 Week Phase 3 MAESTRO-NAFLD-1 Trial

author_avatar
NASDAQ Market News

UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference

RA’ANANA, Israel and NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

author_avatar
NASDAQ Market News

Pueblo Viejo Pays Another $185 Million in Taxes, Bringing Its Total Cash Distribution to the Dominican Government to +$2 Billion

author_avatar
NASDAQ Market News